LHC Group - common stock (LHCG): Price and Financial Metrics
LHC Group - common stock (LHCG)
Today's Latest Price: $177.41 USD
Updated Jul 1 4:00pm
Add LHCG to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 67 in Medical - Services
See all "A" rated Strong Buy stocks
LHCG Stock Summary
- With a one year PEG ratio of 279.36, LHC Group Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 87.53% of US stocks.
- With a price/earnings ratio of 55, LHC Group Inc P/E ratio is greater than that of about 87.16% of stocks in our set with positive earnings.
- The price/operating cash flow metric for LHC Group Inc is higher than 95.97% of stocks in our set with a positive cash flow.
- If you're looking for stocks that are quantitatively similar to LHC Group Inc, a group of peers worth examining would be FND, DECK, COLM, PSN, and BMI.
- Visit LHCG's SEC page to see the company's official filings. To visit the company's web site, go to www.lhcgroup.com.
LHCG Stock Price Chart Technical Analysis Charts
LHCG Price/Volume Stats
| Current price | $177.41 | 52-week high | $179.21 |
| Prev. close | $174.32 | 52-week low | $100.00 |
| Day low | $172.54 | Volume | 314,517 |
| Day high | $179.21 | Avg. volume | 376,140 |
| 50-day MA | $151.87 | Dividend yield | N/A |
| 200-day MA | $135.96 | Market Cap | 5.60B |
LHC Group - common stock (LHCG) Company Bio
LHC Group is a national provider of post-acute healthcare services, providing quality, cost-effective healthcare to patients within the comfort and privacy of their home or place of residence. LHC Group provides a comprehensive array of healthcare services through home health, hospice and community-based services and provides inpatient care through long-term acute care hospitals. The company was founded in 1994 and is based in Lafayette, Louisiana.
LHCG Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $177.41 | $8.2 | -95% |
Below please find a table outlining a discounted cash flow forecast for LHCG, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that LHC Group Inc ranked in the 8th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for LHC Group Inc ended up being:
- The compound growth rate in the free cash flow of LHC Group Inc over the past 5.76 years is -0.01%; that's higher than only 17.66% of free cash flow generating stocks in the Healthcare sector.
- LHCG's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 45.02% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -95% |
| 1% | -95% |
| 2% | -95% |
| 3% | -95% |
| 4% | -95% |
| 5% | -95% |
Want more companies with a valuation profile/forecast similar to that of LHC Group Inc? See CRY, LCTC, PDLI, SRDX, and IVC.
Loading social stream, please wait...